Agoracom: Small Cap Investment - Mosaic ImmunoEngineering Inc. - Re: USPTO-question concerning the person in charge of the 2. examine

Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Reply New Message

Back To Forum List View

USPTO-question concerning the person in charge of the 2. examine

s402005

Jan 24, 2008 01:46AM

drbtmde

Rank: Mail Room [?]

Points: 226 [?]

Votes: 23 Score: 2.2 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: USPTO-question concerning the person in charge of the 2. examine

in response to

USPTO-question concerning the person in charge of the 2. examine

s402005

posted on Jan 24, 2008 02:06AM

TPL/PTSC have now??? 2 months to replay to the USPTO?

I think they received the non-filnal action concerning the 548 and 148 and 336?? patents already in Nov. 2007. The two months time limit to reply should be expired. Maybe I'm wrong???

1 Recommendations

Re: USPTO-question concerning the person in charge of the 2. examine

s402005

Jan 24, 2008 02:10AM

Re: USPTO-question concerning the person in charge of the 2. examine

drbtmde

Jan 24, 2008 02:25AM

Re: USPTO-question drbtmde ....

BaNosser

Jan 24, 2008 05:13AM

Re: USPTO-question drbtmde ....

limerickhook